Dr Camilo Colaço is the founding scientist of ImmBio and is responsible for the scientific programmes and generation of IP. Camilo was previously Director of IP for the biotechnology company Quadrant Healthcare plc. He was responsible for the development of QH’s IP portfolio that formed the basis of its successful IPO and full listing on the London Stock Exchange, and its recent acquisition by Elan Inc. Previously, Dr Colaco was responsible for the management of QH’s R&D portfolio and generating the IP that formed QH’s biomolecule stabilisation and delivery technology.
Prime responsibilities are:
- Scientific programme
- IP
- Delivery formats
- New technology generation/ acquisition
Qualifications
- BSc (1st Class Honours), Biochemistry, University of London
- MRC PhD Studentship, N.I.M.R. Mill Hill
Experience
- Director IP, Quadrant Healthcare plc
- Vice-President of IP, Quadrant Holdings
- Director, Quadrant Research Foundation, Cambridge
- Lecturer, Clinical School, University of Cambridge
- Royal Society Fellow, EMBL, Heidelberg, Germany
- ICRF Fellow, ICRF Laboratories, London
- BHF-AHA Fellow, CALTECH, Pasadena, USA
Other
- Extensive publications
- Significant patenting & litigation experience
|
